Ledger.Open graph →
SEC Form D · filed March 7, 2012

KOLLTAN PHARMACEUTICALS INC

Offering
$25.0M
Sold
$25.0M
Exemption
Industry
Biotechnology
Location
NEW HAVEN, CT
Type

People & firms on this filing (12)

Michael Schmertzler · New Haven, CTExec · DirectorW. B. Middlekauff · New Haven, CTExecBrian G. Lancaster · SAN FRANCISCO, CADirectorIlan Weinberg · Darien, CTDirectorPetr Marousek · Darien, CTDirectorJames D. Howard, Jr · Phoenix, AZExecJoseph F. Campagna · Reston, VAExecTC Georgia II LLC · Phoenix, AZDirectorTC Georgia LLC · Phoenix, AZDirectorLeonard S. Polonsky · Douglas, Y8DirectorLeigh R. Goehring · Stamford, CTExec · DirectorJames Henderson · Stamford, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗